3 investors at Digitalis Ventures, based in Boston, MA.
Back to Digitalis Ventures profile
Founder and Managing Partner, Digitalis Ventures
Geoffrey W. Smith trains physicians and scientists to become entrepreneurs through his Columbia University course while serving as CEO of Alcea Therapeutics, combining hands-on operating experience with his role as Managing Partner of Digitalis Ventures. He chairs the Board of Trustees at Central European University and founded the nonprofit Digitalis Commons focused on public-minded health innovation, extending his influence beyond typical venture capital into global education and civic-oriented health infrastructure.

Principal, Digitalis Ventures
Jonathan Friedlander is a Principal at Digitalis Ventures, a venture capital firm focused on identifying and supporting transformative companies at the intersection of biology, technology, and medicine. With a strategic focus on biotech, digital health, AI, and deeptech, Jonathan brings investment expertise to early-stage and growth-stage ventures poised to reshape healthcare and scientific innovation. At Digitalis Ventures, he evaluates opportunities across the life sciences and technology sectors, working with founding teams to scale breakthrough technologies and solutions. His investment thesis centers on companies leveraging cutting-edge artificial intelligence, computational biology, and digital platforms to address critical healthcare challenges and advance scientific discovery. Jonathan is committed to partnering with visionary entrepreneurs who are building the future of precision medicine and next-generation biotechnology.

Partner, Digitalis Ventures
Samuel Bjork is a Partner at Digitalis Ventures, a venture capital firm focused on identifying and supporting transformative companies at the intersection of technology and life sciences. With expertise spanning biotech, digital health, artificial intelligence, and deeptech, Bjork invests in innovative founders and technologies poised to reshape industries and improve human outcomes. At Digitalis Ventures, he leverages his investment acumen to identify promising early-stage opportunities and provide strategic guidance to portfolio companies navigating complex technical and market challenges. Bjork's multidisciplinary focus reflects a commitment to backing bold innovation across sectors where cutting-edge technology meets meaningful real-world application. Through his work, he connects with entrepreneurs, engineers, and scientists developing the next generation of breakthrough solutions in healthcare, computing, and advanced technologies.
Digitalis Ventures's investment team consists of 3 professionals, headquartered in Boston, MA. The team brings diverse backgrounds and specialized expertise to evaluate and support portfolio companies.
Across the team, Digitalis Ventures's investors cover expertise in Biotech, Digital Health, AI, Deeptech. This breadth of sector knowledge enables the firm to evaluate opportunities across multiple verticals and provide specialized post-investment support to founders.
Digitalis Ventures has 3 investors and partners on their team, based in Boston, MA. Each team member brings specialized expertise across different sectors and investment stages.
Digitalis Ventures's team consists of 3 investment professionals. View individual investor profiles above for detailed backgrounds, focus areas, and portfolio companies.
Newsletter
Join thousands of founders and investors. Every Tuesday.